Taurus Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Taurus Asset Management's LLY Position: Q1 2025 in Review
Taurus Asset Management reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2025, selling an estimated $33.3K and leaving 2,388 shares worth $1.97M. The position accounts for 0.2% of the portfolio, ranked #47.
Taurus Asset Management first reported a position in LLY in Q4 2017 and has held it in 30 quarters since. The position peaked at $2.32M in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Taurus Asset Management held 2,388 shares of Eli Lilly worth $1.97M as of Q1 2025.
- Taurus Asset Management sold 40 Eli Lilly shares in Q1 2025, an estimated $33.3K.
- Eli Lilly made up 0.2% of Taurus Asset Management's portfolio in Q1 2025, its #47 holding.
- Taurus Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 30 quarters since.
- Taurus Asset Management's Eli Lilly position peaked at $2.32M in Q2 2024.
- 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Taurus Asset Management's 13F filing for Q1 2025, filed 13 May 2025.